Targeting Inflammation in the Diagnosis, Management, and Prevention of Cardiovascular Diseases

Area of Science:

• Cardiovascular Science
• Immunology
• Nutritional Science

Background:

• Inflammation is a key driver in the development and progression of cardiovascular diseases (CVDs).
• Hypertension, hyperlipidemia, unhealthy diet, infection, smoking, and genetic factors contribute to CVDs and inflammation.
• Risk factors like hypertension, hyperlipidemia, and diabetes activate nuclear factor kappa B, promoting inflammatory molecule production.

Purpose of the Study:

• To review the role of inflammation in cardiovascular disease (CVD) pathogenesis.
• To discuss novel inflammation biomarkers, specifically free light chains (FLCs).
• To explore dietary interventions, such as Pycnogenol, for counterbalancing inflammation.

Main Methods:

• Literature review of existing research on inflammation, CVDs, biomarkers, and dietary factors.
• Analysis of the role of nuclear factor kappa B signaling in inflammation.
• Examination of the association between FLC levels and cardiovascular outcomes.

Main Results:

• Inflammation significantly contributes to the pathogenesis of CVDs.
• Free light chains (FLCs) are identified as novel biomarkers for inflammation.
• Elevated FLC levels correlate with increased overall mortality and adverse cardiovascular outcomes.

Conclusions:

• Inflammation is a critical factor in cardiovascular disease.
• Free light chains (FLCs) show promise as predictive biomarkers for cardiovascular risk.
• Dietary components like Pycnogenol may offer a strategy to mitigate inflammatory processes in CVDs.